HealthTech: Biomarkers for eye disease | Next-gen imaging tech | Pinpoint pain
-
BLOOMINGTON, IN—Researchers at Indiana University have identified new biomarkers that may advance the early detection of diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in U.S. adults.
- ST. LOUIS, MO—An assistant professor at the McKelvey School of Engineering at Washington University in St. Louis will be leading a three-year research initiative to accelerate the development of the next generation of imaging technologies. Ulugbek Kamilov has already designed algorithms to shave time off of MRI scans and worked on software aimed at tailoring unwieldy amounts of data into manageable datasets.
- INDIANAPOLIS, IN—An experimental eczema medicine from Eli Lilly called lebrikizumab has succeeded in two late-stage clinical trials. The drug was developed by Dermira, a company Lilly acquired in 2019 for just over $1 billion.
- PITTSBURGH, PA—The University of Pittsburgh has paved the way for more personalized medicine by using a body map to pinpoint pain distribution. Researchers found that how a patient reports the bodily distribution of their chronic pain affects nearly all aspects of the pain experience.